SE469059B - Anvaendning av acyloxialkanoylkolinsalt foer framstaellning av laekemedel foer behandling av neuropsykiatriska symtom som aatfoeljer demens - Google Patents

Anvaendning av acyloxialkanoylkolinsalt foer framstaellning av laekemedel foer behandling av neuropsykiatriska symtom som aatfoeljer demens

Info

Publication number
SE469059B
SE469059B SE8604950A SE8604950A SE469059B SE 469059 B SE469059 B SE 469059B SE 8604950 A SE8604950 A SE 8604950A SE 8604950 A SE8604950 A SE 8604950A SE 469059 B SE469059 B SE 469059B
Authority
SE
Sweden
Prior art keywords
acyloxyalkanoylcholine
salt according
dementia
salt
neuropsychiatric symptoms
Prior art date
Application number
SE8604950A
Other languages
English (en)
Swedish (sv)
Other versions
SE8604950D0 (sv
SE8604950L (sv
Inventor
F Kuzuya
H Endo
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of SE8604950D0 publication Critical patent/SE8604950D0/xx
Publication of SE8604950L publication Critical patent/SE8604950L/
Publication of SE469059B publication Critical patent/SE469059B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8604950A 1985-11-19 1986-11-19 Anvaendning av acyloxialkanoylkolinsalt foer framstaellning av laekemedel foer behandling av neuropsykiatriska symtom som aatfoeljer demens SE469059B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60257881A JPH0733332B2 (ja) 1985-11-19 1985-11-19 痴呆症状改善・治療剤

Publications (3)

Publication Number Publication Date
SE8604950D0 SE8604950D0 (sv) 1986-11-19
SE8604950L SE8604950L (sv) 1987-05-20
SE469059B true SE469059B (sv) 1993-05-10

Family

ID=17312478

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604950A SE469059B (sv) 1985-11-19 1986-11-19 Anvaendning av acyloxialkanoylkolinsalt foer framstaellning av laekemedel foer behandling av neuropsykiatriska symtom som aatfoeljer demens

Country Status (12)

Country Link
US (1) US4713376A (de)
JP (1) JPH0733332B2 (de)
AU (1) AU590640B2 (de)
CA (1) CA1278519C (de)
CH (1) CH668184A5 (de)
DE (1) DE3639378A1 (de)
DK (1) DK169607B1 (de)
FR (1) FR2590170B1 (de)
GB (1) GB2184653B (de)
IT (1) IT1200041B (de)
NL (1) NL8602933A (de)
SE (1) SE469059B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
ES2162520T3 (es) * 1998-02-13 2001-12-16 Schwabe Willmar Gmbh & Co Medicamentos basados en hiperforina y/o extractos de hiperforina.
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005019157A1 (en) * 2003-08-15 2005-03-03 Patel Hasmukh B Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
US7803842B2 (en) * 2004-06-08 2010-09-28 Hass Patel Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
WO2006059252A2 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
AU2006342958A1 (en) * 2005-12-22 2007-11-08 Bellus Health (International) Limited Treatment of renal disorders, diabetic nephropathy and dyslipidemias
WO2009019534A2 (en) 2006-10-12 2009-02-12 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
EP2120905A1 (de) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Verfahren, verbindungen und zusammensetzungen zur behandlung von stoffwechselerkrankungen und diabetes
NZ578475A (en) * 2007-02-07 2011-05-27 Pulmagen Therapeutics Synergy Napadisylate salt of a muscarinic m3 antagonist
TW201115409A (en) * 2009-10-29 2011-05-01 Hannspree Inc A mouse capable of generating vapor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336350A (en) * 1970-12-28 1973-11-07 Toyama Chemical Co Ltd Choline derivatives and process for producing the same
DE2425983C3 (de) * 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung
JPS5221490A (en) * 1975-08-12 1977-02-18 Mitsubishi Rayon Co Printing method
JPS592904B2 (ja) * 1976-09-18 1984-01-21 日本ビクター株式会社 デイスプレイ装置
JPS551251A (en) * 1978-06-20 1980-01-08 Yamaha Motor Co Ltd Brake pedal for motorcycle
JPS58180463A (ja) * 1982-04-19 1983-10-21 Toyama Chem Co Ltd ビスコリンジスルホナ−ト類の製造法

Also Published As

Publication number Publication date
GB2184653A (en) 1987-07-01
DE3639378C2 (de) 1990-05-10
IT1200041B (it) 1989-01-05
SE8604950D0 (sv) 1986-11-19
GB2184653B (en) 1989-11-15
DK550586A (da) 1987-05-20
NL8602933A (nl) 1987-06-16
DK550586D0 (da) 1986-11-18
GB8627484D0 (en) 1986-12-17
AU590640B2 (en) 1989-11-09
JPH0733332B2 (ja) 1995-04-12
JPS62120317A (ja) 1987-06-01
US4713376A (en) 1987-12-15
SE8604950L (sv) 1987-05-20
AU6530286A (en) 1987-05-21
DE3639378A1 (de) 1987-05-27
DK169607B1 (da) 1994-12-27
CH668184A5 (de) 1988-12-15
CA1278519C (en) 1991-01-02
FR2590170A1 (fr) 1987-05-22
FR2590170B1 (fr) 1990-08-24
IT8648670A0 (it) 1986-11-19

Similar Documents

Publication Publication Date Title
SE469059B (sv) Anvaendning av acyloxialkanoylkolinsalt foer framstaellning av laekemedel foer behandling av neuropsykiatriska symtom som aatfoeljer demens
EP0760664B1 (de) Verwendung von pteridin-derivaten als hemmstoffe der no-synthase
EP0713704A1 (de) 2-Amino-1,3-thiazine als Hemmstoffe der Stickstoffmonoxid-Synthase
JPH10316567A (ja) 過敏性腸症候群の症状の治療用のｎｋ−１受容体アンタゴニスト
SE450251B (sv) Xantatforeningar for terapeutisk anvendning, nya xantatforeningar samt terapeutiska kompositioner innehallande dessa foreningar
HU201672B (en) Process for producing pharmaceutical compositions comprising podophyllotoxin
US6399658B1 (en) Composition containing ascorbic acid
DE69912842T2 (de) Antivirale nukleosidanaloga
CN114555577A (zh) 用于治疗门静脉炎症和纤维化的噻吩衍生物
JPH0232015A (ja) 薬剤の製造のためのモノ置換セレン有機化合物の使用、ならびにそれから製造される薬剤およびその薬剤の製造方法
US5789407A (en) Method of treating depression with certain triazine derivatives
JPS58174313A (ja) 動物組織の線維化抑制剤
EP1084704B1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
HU190597B (en) Process for preparing synrtgetic pharmaceutical compositions
EP0137514B1 (de) Verbindungen und Zusammensetzungen verwendbar bei der Prävention und Behandlung von Obesitas
NZ204072A (en) Pharmaceutical compositions which contain theophylline as active ingredient
US3885034A (en) Phenothiazine derivatives in the treatment of psychotic persons
US4469707A (en) Method for treatment of senile dementia
JPH05504550A (ja) 免疫抑制剤として有用なピリミジン生合成インヒビター
US3891769A (en) Psychotherapeutic methods employing thioureas
DE60026559T2 (de) Arzneimittel gegen essstörungen
JPH04208223A (ja) 肝臓疾患治療剤
WO1991001136A1 (de) Tetrahydrobenzthiazolderivate zur behandlung von augenkrankheiten
JPH03232870A (ja) チオアミド化合物
IL44357A (en) Anthelmintic composition containing 2-benzoyl-4-oxo-1,2,3,6,7,11b-hexahydro-4h-pyrazino (2,1-a) isoquinoline

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8604950-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8604950-9

Format of ref document f/p: F